chrX-17376088-TCGG-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_001291867.2(NHS):βc.348_350delβ(p.Ala117del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000144 in 1,074,393 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (β β ).
Frequency
Genomes: π 0.000018 ( 0 hom., 1 hem., cov: 23)
Exomes π: 0.00016 ( 0 hom. 3 hem. )
Consequence
NHS
NM_001291867.2 inframe_deletion
NM_001291867.2 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.51
Genes affected
NHS (HGNC:7820): (NHS actin remodeling regulator) This gene encodes a protein containing four conserved nuclear localization signals. The encoded protein functions in eye, tooth, craniofacial and brain development, and it can regulate actin remodeling and cell morphology. Mutations in this gene have been shown to cause Nance-Horan syndrome, and also X-linked cataract-40. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, May 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Hemizygotes in GnomAdExome4 at 3 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NHS | NM_001291867.2 | c.348_350del | p.Ala117del | inframe_deletion | 1/9 | ENST00000676302.1 | NP_001278796.1 | |
NHS | NM_198270.4 | c.348_350del | p.Ala117del | inframe_deletion | 1/8 | NP_938011.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NHS | ENST00000676302.1 | c.348_350del | p.Ala117del | inframe_deletion | 1/9 | NM_001291867.2 | ENSP00000502262 | P4 | ||
NHS | ENST00000380060.7 | c.348_350del | p.Ala117del | inframe_deletion | 1/8 | 1 | ENSP00000369400 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000181 AC: 2AN: 110363Hom.: 0 Cov.: 23 AF XY: 0.0000300 AC XY: 1AN XY: 33335
GnomAD3 genomes
AF:
AC:
2
AN:
110363
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
33335
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000159 AC: 153AN: 964030Hom.: 0 AF XY: 0.00000984 AC XY: 3AN XY: 304798
GnomAD4 exome
AF:
AC:
153
AN:
964030
Hom.:
AF XY:
AC XY:
3
AN XY:
304798
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000181 AC: 2AN: 110363Hom.: 0 Cov.: 23 AF XY: 0.0000300 AC XY: 1AN XY: 33335
GnomAD4 genome
AF:
AC:
2
AN:
110363
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
33335
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jun 12, 2013 | - - |
Nance-Horan syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 30, 2023 | This variant, c.348_350del, results in the deletion of 1 amino acid(s) of the NHS protein (p.Ala117del), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with NHS-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at